Robert B Bazemore's Net Worth
$840 Thousand
Who is Robert B Bazemore?
Robert B Bazemore does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Nuvation Bio Inc., Neon Therapeutics, Inc., ARDELYX, INC., Epizyme, Inc., and SYNAGEVA BIOPHARMA CORP.
SEC CIK
Robert B Bazemore's CIK is 0001620152
Past Insider Trading and Trends
2020 was Robert B Bazemore's most active year for acquiring shares with 9 total transactions. Robert B Bazemore's most active month to acquire stocks was the month of May. 2020 was Robert B Bazemore's most active year for disposing of shares, totalling 13 transactions. Robert B Bazemore's most active month to dispose stocks was the month of May. 2020 saw Robert B Bazemore paying a total of $89,800.00 for 552,103 shares, this is the most they've acquired in one year. In 2020 Robert B Bazemore cashed out on 280,436 shares for a total of $765,340.55, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Nuvation Bio Inc. (NUVB) Snapshot price: $2.85
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 29
| |||
Form 4
|
∞
| 5K |
$9.98 | $49,899.50 | 5K |
Mar 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neon Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARDELYX, INC. (ARDX) Snapshot price: $5.61
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
President & CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -3.10% | -10.33K |
$7.85 | -$81,074.80 | 322.63K |
Scheduled
|
Mar 25
| ||
Form 4
| -1.16% | -3.89K |
$11.21 | -$43,606.90 | 331.98K |
Scheduled
|
Feb 4
| ||
Form 4
| +35.23% | 87.5K |
—
|
—
| 335.87K |
Feb 1
| |||
Form 4
| -2.39% | -6.07K |
$11.41 | -$69,247.29 | 248.37K |
Scheduled
|
Jan 25
| ||
Form 4
| +2.34% | 5.73K |
$16.15 | -$77,083.95 | 250.1K |
Scheduled
|
Jun 25 - Jun 26
| ||
Form 4
| -3.93% | -10.00K |
$15.49 | -$350,200.00 | 244.37K |
Scheduled
|
Jun 18
| ||
Form 4
| +22.06% | 60.57K |
$15.28 | -$50,194.80 | 335.1K |
Scheduled
|
Mar 24 - Mar 25
| ||
Form 4
| +62.12% | 52.59K |
—
|
—
| 137.26K |
Feb 3
| |||
Form 4
| -0.38% | -326.00 |
$21.82 | -$198,061.80 | 84.67K |
Scheduled
|
Jan 23 - Jan 27
| ||
Form 4
| +6.15% | 4.93K |
$12.10 | -$25,095.40 | 84.99K |
Scheduled
|
Jun 12 - Jun 13
| ||
Form 4
| +1,609.03% | 75.38K |
—
|
—
| 80.07K |
Jan 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4
| +125.40% | 1.71K |
$6.21 | $10,612.66 | 3.07K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
∞
| 1.36K |
$6.21 | $8,462.79 | 1.36K |
Aug 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
SYNAGEVA BIOPHARMA CORP No price found
Chief Operating Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -35.00K |
—
|
—
|
0
|
Jun 22
| |||
Form 4
| +16.67% | 5K |
—
|
—
| 35K |
Jun 5
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
Sep 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||